Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03241940
Title Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Crystal Mackall, MD

acute lymphoblastic leukemia



Cyclophosphamide + Fludarabine

CD19/CD22 CAR T cells

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.